Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
DeCampo Antonella |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Lichtenegger, K; Kopanz, J; Libiseller, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Beck, P; Holl, B; Pieber, T; De Campo, A
DIGITAL DECISION SUPPORT FOR BASAL INSULIN THERAPY: RCT CONFIRMED READINESS FOR IMPLEMENTATION IN ACUTE-GERIATRIC CARE PATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A110-A111.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-22, 2020; Madrid, SPAIN.
[Poster]
Web of Science
Libiseller, A; Lichtenegger, KM; Kopanz, J; De Campo, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Lackner, BC; Beck, P; Holl, B; Pieber, TR
Improving Glycemic Management of Patients with Type 2 Diabetes in Acute Geriatric Care by Using a Basal Insulin Algorithm Incorporated into a Workflow and Decision Support System
DIABETES. Diabetes 2019 Jun; 68(Supplement 1): -. . 2019; 68: -79th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 07-11, 2019; San Francisco, CA.
Doi: 10.2337/db19-952-P
[Poster]
Web of Science
FullText
FullText_MUG
Libiseller, A; Lichtenegger, K; de Campo, A; Wiesinger, T; Stolletz, N; Cuder, G; Beck, P; Plank, J; Holl, B; Pieber, T
HEALTH STATUS AND GLYCAEMIC CONTROL IN GERIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
DIABETES TECHNOL THE. 2018; 20: A65-A65.-ATTD; Vienna, Austria.
[Poster]
Web of Science
Libiseller, A; Lichtenegger, KM; de Campo, A; Wiesinger, T; Stolletz, N; Cuder, G; Höll, B; Beck, P; Pieber, TR
GLYCAEMIC MANAGEMENT IN PATIENTS WITH
TYPE 2 DIABETES IN GERIATRIC CARE FACILITIES.
Abstracts from ATTD 2017
10th International Conference on
Advanced Technologies & Treatments for Diabetes
Paris, France—February 15–18, 2017. 2017; 19(S1):A-53--The 10th international conference on advanced technologies and treatments for diabetes; FEB 15-18, 2017; Paris.
[Poster]
FullText
Libiseller, A; Lichtenegger, KM; de Campo, A; Wiesinger, T; Stolletz, N; Cuder, G; Holl, B; Schaupp, L; Beck, P; Plank, J; Pieber, TR
Glycemic Control in Patients with Type-2-Diabetes in geriatric Facilities depending on the Diabetes Therapy
WIEN KLIN WOCHENSCHR. 2017; 129: 179-180.
[Poster]
Web of Science
Libiseller, A; Neubauer, KM; De Campo, A; Wiesinger, T; Stolletz, N; Cuder, G; Holl, B; Schaupp, L; Beck, P; Plank, J; Pieber, TR
Glycemic Control of Female Patients with Type 2 Diabetes with different Health Status in geriatric Institutions
WIEN KLIN WOCHENSCHR. .. 2016; 128: S398-S398.
[Poster]
Web of Science
Maierhofer, S; deCampo, A; Stojakovic, T; Jahnel, H; Toplak, H
EFFECTIVITY OF COLESEVELAM IN STATIN INTOLERANT PATIENTS ± EZETIMIBE.
ATHEROSCLER SUPPL. 2011; 12(1):163-163.-79th Congress of the European Atherosclerosis Society (EAS); JUN 26-29, 2011; Gothenburg, SWEDEN.
Doi: 10.1016/S1567-5688(11)70779-6
[Poster]
Web of Science
FullText
FullText_MUG
Mahajan, V; Klingstedt, T; Simon, R; Nilsson, KP; Thueringer, A; Kashofer, K; Haybaeck, J; Denk, H; Abuja, PM; Zatloukal, K
Luminescent Conjugated Oligothiophenes: A novel class of affinity binders for characterization of inclusions in diseased liver.
Biobanking for Science; September 22-25,2010; Amsterdam. 2010.
[Poster]
Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W
Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients with type 2 diabetes and/or coronary heart disease.
Clin Chem Lab Med 2009; 47(9):A47-A47.-6th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL); OCT 7-10, 2009; Leipzig, GERMANY.
[Poster]
Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, I; Schmolzer, I; Wascher, TC; Marz, W
Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A20-A20.-40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA.
[Poster]
Web of Science
Scharnagl, H; Stojakovic, T; De Campo, A; Wascher, T; März, W
The effect of fluvastatin and ezetimib on dense low density lipoproteins in patients with hypercholesterolemia and CHD.
15. Jahrestagung der Austrian Atherosclerosis Society (AAS). ; APR 18-19, 2008; St.Gilgen, AUSTRIA. 2008.
[Poster]
Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W
Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.
38. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 27-29, 2008; Maikammer, Deutschland. 2008.
[Oral Communication]
Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W
Effekte von Fluvastatin-Monotherapie oder in Kombination mit Ezetimibe auf LDL-Subfraktionen in einem Hochrisikokollektiv.
Wien Klin Wochenschr 2008; 120/19-20: S22-S22.-36. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 20-22, 2008; Baden, AUSTRIA.
[Oral Communication]
DeCampo, A; Schmoelzer, I; Kettler-Schmut, E; Sourij, H; Forst, I; Wascher, IC
Non-glycaemic effects of insulin-therapy: a comparison between insulin aspart and normal insulin during two consecutive meals in patients with type 2 diabetes
DIABETOLOGIA. 2007; 50: S412-S413.-Annual Meeting of the EASD; SEP 17-21, 2007; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
Schmölzer, I; Schmut, E; de Campo, A; Sourij, H; Wascher, T
Stabilerer Glukoseverlauf über zwei aufeinanderfolgende Mahlzeiten bei Typ 2 Diabetikern unter Novorapid.
Diabetologie und Stoffwechsel. 1: S82-S82.-Jahrestagung der Deutschen Diabetesgesellschaft 2006; MAY 24-27, 2006; Leipzig, Germany.
[Poster]
Winklhofer-Roob, BM; Jerlich, A; de Campo, A; Roob, JM; Schaur, RJ; Toplak, H; Paulweber, B
LDL susceptibility to copper- and hypochlorite-mediated oxidation in familial defective apolipoprotein B-100 (FDB).
FASEB J 2000 14: A521-A521.
Web of Science